Scholarlink

<p>Black flies (Simulidae) employ salivary peptides to optimize blood-feeding efficiency through anticoagulation and analgesia, yet the molecular mechanisms underlying their analgesic effects remain unclear. Here, we identified a novel Kunitz-type peptide, sibanin, from <i>Simulium bannaense</i> venom, which exhibits both potent analgesic and anticoagulant properties. Using pain activity tracking, HPLC, and electrophysiological techniques, we found that sibanin potently inhibited the Na<sub>V</sub>1.7 channel (IC<sub>50</sub>: 265.03 ± 7.86 nM), selectively reducing pain signal transmission in mouse thermal pain models. Mutagenesis studies identified critical residues (N209 and A1585) in the Na<sub>V</sub>1.7 voltage-sensing domain (S3b-S4a) essential for sibanin binding, conserved across vertebrate hosts. Concurrently, sibanin inhibited coagulation factors (e.g., FXa) and proteases, preventing thrombus formation. This dual functionality enables black flies to suppress host pain perception and ensure continuous blood flow during feeding. The unique synergy of Na<sub>V</sub>1.7-targeted analgesia and anticoagulation highlights sibanin’s potential as a lead compound for dual-action therapeutics in pain management and thrombotic disease treatment, circumventing polypharmacy risks. Our findings elucidate a conserved evolutionary strategy in hematophagous insects and provide a foundation for developing multifunctional pharmacological agents.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dual-action salivary peptide drives black fly feeding efficiency

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月23日

查看全文
  • Xiaopei Yang,
  • Yanmei He,
  • Xiaoli Feng,
  • Guixi Wang,
  • Xiaoyan Zhou,
  • Lixian Mu,
  • Jing Wu,
  • Hailong Yang

摘要

Black flies (Simulidae) employ salivary peptides to optimize blood-feeding efficiency through anticoagulation and analgesia, yet the molecular mechanisms underlying their analgesic effects remain unclear. Here, we identified a novel Kunitz-type peptide, sibanin, from Simulium bannaense venom, which exhibits both potent analgesic and anticoagulant properties. Using pain activity tracking, HPLC, and electrophysiological techniques, we found that sibanin potently inhibited the NaV1.7 channel (IC50: 265.03 ± 7.86 nM), selectively reducing pain signal transmission in mouse thermal pain models. Mutagenesis studies identified critical residues (N209 and A1585) in the NaV1.7 voltage-sensing domain (S3b-S4a) essential for sibanin binding, conserved across vertebrate hosts. Concurrently, sibanin inhibited coagulation factors (e.g., FXa) and proteases, preventing thrombus formation. This dual functionality enables black flies to suppress host pain perception and ensure continuous blood flow during feeding. The unique synergy of NaV1.7-targeted analgesia and anticoagulation highlights sibanin’s potential as a lead compound for dual-action therapeutics in pain management and thrombotic disease treatment, circumventing polypharmacy risks. Our findings elucidate a conserved evolutionary strategy in hematophagous insects and provide a foundation for developing multifunctional pharmacological agents.